Skip to content

Impact of Perivascular Tissue on Endothelial Function in Coronary Artery Bypass Grafting

Impact of Perivascular Tissue on Endothelial Function and Vessel Structure in Vein Grafts Used for Coronary Artery Bypass Grafting: A Prospective, Randomized Controlled Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01834846
Acronym
IMPROVE-CABG
Enrollment
100
Registered
2013-04-18
Start date
2013-05-31
Completion date
2021-12-31
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Ischemia

Keywords

comparative study, Cardiac Surgical Procedures

Brief summary

The success of coronary artery bypass grafting is reliant on the quality of the grafts used. A new technique for harvesting veins used as grafts has been introduced. The study hypothesis is that veins harvested with this technique have an improved endothelial function.

Interventions

PROCEDUREno-touch

The saphenous vein is exposed by a longitudinal incision, and all visible side branches ligated. The vein is then isolated together with a pedicle of surrounding tissue and manually distended and stored in a combination of blood and saline using a syringe, according to standard procedure at St. Olav's Hospital.

PROCEDUREconventional

The saphenous vein is exposed by a longitudinal leg incision, skeletonized from surrounding tissue, and side branches ligated. The vein is removed from the leg immediately after dissection, manually distended and stored in a combination of blood and saline using a syringe, according to standard procedure at St. Olav's Hospital.

Sponsors

St. Olavs Hospital
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Isolated elective, primary CABG requiring cardiopulmonary bypass * Left ventricular ejection fraction \>35% * at least one saphenous vein graft required as part of revascularization strategy

Exclusion criteria

* Acute or chronic inflammatory diseases * Malignancies * Pregnancy * Previous cardiac surgery * Serum creatinine \>120 μmol/L * Coagulopathy * Insulin dependent diabetes mellitus * Smoking during last 6 months * Leg not suitable for No-touch vein harvesting as judged by the operator. * Need for nitrates on operation day * not receiving statins

Design outcomes

Primary

MeasureTime frameDescription
Graft function6 monthsGraft function as evaluated by coronary angiography in the first 60 out of 100 patients

Secondary

MeasureTime frameDescription
Morphological appearance of vein graft6 monthsAs measured by angiography follow-up in the first 60 out of 100 patients
Postoperative leg wound complications6 weeksThe following measures will be assessed in the first 60 out of 100 patients: * Signs of infection * Wound dehiscence * Aesthetics * Cutaneous sensory loss * Wound discomfort
Postoperative complications related to cardiac surgeryDischarge, 6 weeks, 6 monthsMajor adverse cardiac and cerebral events in the first 60 out of 100 patients * Postoperative complications * Reoperation * Sternal dehiscence * Mediastinitis

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026